These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11773151)

  • 21. Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).
    Frasci G; Comella P; D'Aiuto G; Thomas R; Capasso I; Elmo M; Botti G; Cortino GR; Lapenta L; De Rosa V; Vallone P; Petrillo A; Comella G
    Ann Oncol; 2000 Mar; 11(3):367-71. PubMed ID: 10811508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.
    Martoni A; Marino A; Sperandi F; Giaquinta S; Di Fabio F; Melotti B; Guaraldi M; Palomba G; Preti P; Petralia A; Artioli F; Picece V; Farris A; Mantovani L
    Eur J Cancer; 2005 Jan; 41(1):81-92. PubMed ID: 15617993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
    Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
    Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor.
    Haider K; Kornek GV; Kwasny W; Weinländer G; Valencak J; Lang F; Püribauer F; Kovats E; Depisch D; Scheithauer W
    Breast Cancer Res Treat; 1999 Jun; 55(3):203-11. PubMed ID: 10517165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.
    Nicolaides C; Dimopoulos MA; Samantas E; Bafaloukos D; Kalofonos C; Fountzilas G; Razi E; Kosmidis P; Pavlidis N
    Ann Oncol; 2000 Jul; 11(7):873-5. PubMed ID: 10997817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer.
    Dong N; Wang M; Li H; Cui Y; Guo Q
    Cancer Chemother Pharmacol; 2012 May; 69(5):1315-22. PubMed ID: 22307763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain.
    Colomer R; Llombart-Cussac A; Tusquets I; Rifà J; Mayordomo JI; Ojeda B; Ciruelos E; Hornedo J; Vicente D; Cortés-Funes H
    Clin Transl Oncol; 2006 Dec; 8(12):896-902. PubMed ID: 17169763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer.
    Lorusso V; Crucitta E; Silvestris N; Guida M; Misino A; Latorre A; De Lena M
    Clin Breast Cancer; 2003 Jun; 4(2):138-41. PubMed ID: 12864942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.
    Vici P; Fabi A; Metro G; Sergi D; Giannarelli D; Di Lauro L; Bepler G; Tomao F; Cognetti F; Conti F; Lopez M
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):687-93. PubMed ID: 20512334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biweekly vinorelbine and gemcitabine as second-line treatment and beyond in non-small cell lung cancer.
    Chelis L; Xenidis N; Amarantidis K; Prassopoulos P; Chamalidou E; Neanidis K; Mikroulis D; Chatzaki E; Karakitsos P; Kakolyris S
    Chemotherapy; 2010; 56(5):353-8. PubMed ID: 20926858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial.
    Laack E; Mende T; Dürk H; Kneba M; Dickgreber N; Welte T; Müller T; Scholtze J; Graeven U; Jasiewicz Y; Edler L; Hossfeld DK
    Eur J Cancer; 2002 Mar; 38(5):654-60. PubMed ID: 11916547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine and vinorelbine combination in patients with metastatic breast cancer.
    Sanal SM; Gokmen E; Karabulut B; Sezgin C
    Breast J; 2002; 8(3):171-6. PubMed ID: 12047474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer.
    Welt A; von Minckwitz G; Oberhoff C; Borquez D; Schleucher R; Loibl S; Harstrick A; Kaufmann M; Seeber S; Vanhoefer U
    Ann Oncol; 2005 Jan; 16(1):64-9. PubMed ID: 15598940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study.
    Frasci G; Panza N; Comella P; Nicolella GP; Natale M; Pacilio C; Gravina A; Caputi V; Botti G; Comella G
    Ann Oncol; 1997 Oct; 8(10):1045-8. PubMed ID: 9402180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gemcitabine and vinorelbine in pretreated advanced breast cancer: a pilot study.
    Valenza R; Leonardi V; Gebbia V; Agostara B
    Ann Oncol; 2000 Apr; 11(4):495-6. PubMed ID: 10847474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
    Lorusso V; Crucitta E; Panza N; Silvestris N; Guida M; Carpagnano F; Mancarella S; Sambiasi D; De Lena M
    Ann Oncol; 2002 Dec; 13(12):1862-7. PubMed ID: 12453853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.
    Medioni J; Huchon C; Le Frere-Belda MA; Hofmann H; Bats AS; Eme D; Andrieu JM; Oudard S; Lecuru F; Levy E
    Drugs R D; 2011; 11(2):147-57. PubMed ID: 21679005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.
    Karampeazis A; Vamvakas L; Agelaki S; Kentepozidis N; Papadimitraki E; Gioulbasanis I; Vardakis N; Ignatiadis M; Mavroudis D; Georgoulias V
    Oncology; 2006; 71(5-6):347-53. PubMed ID: 17785992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naïve non-small cell lung cancer.
    Keskin S; Tas F; Ekenel M; Kilic L; Sen F; Yildiz I; Karabulut S; Ciftci R; Vatansever S
    Tumori; 2013; 99(4):463-8. PubMed ID: 24326833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer.
    de Carpeño JC; Barón MG; Aguiar J; Chacón JI; Feliu J; García MJ; Madroñal C; Colmenarejo A; Sánchez JJ; Ordóñez A;
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):266-71. PubMed ID: 16308698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.